In Table 2, by network pharmacology analysis, we have showed the intersection genes between JPFR and intestinal cancer targets, such as GSK3B, CCND1, HIF-1A, MYC, CCNB1, and CD44, implying the vital regulatory effect of JPFR on Wnt/β-catenin signaling. Here, CCNB1 is linked to intestinal cancer.